A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)

NCT05143177 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
SUSPENDED
Status
580
Enrollment
INDUSTRY
Sponsor class

Stopped The study is suspended due to sponsor's business decision. There were no safety issues influencing this course of action.

Conditions

Interventions

Sponsor

REDNVIA Co., Ltd.